243 related articles for article (PubMed ID: 24628760)
1. Functional proteomic analysis reveals the involvement of KIAA1199 in breast cancer growth, motility and invasiveness.
Jami MS; Hou J; Liu M; Varney ML; Hassan H; Dong J; Geng L; Wang J; Yu F; Huang X; Peng H; Fu K; Li Y; Singh RK; Ding SJ
BMC Cancer; 2014 Mar; 14():194. PubMed ID: 24628760
[TBL] [Abstract][Full Text] [Related]
2. Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma.
Zhai X; Wang W; Ma Y; Zeng Y; Dou D; Fan H; Song J; Yu X; Xin D; Du G; Jiang Z; Zhang H; Zhang X; Jin B
Aging (Albany NY); 2020 Nov; 12(23):23761-23777. PubMed ID: 33197891
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the role of KIAA1199, a novel endoplasmic reticulum protein, in cancer cell migration.
Evensen NA; Kuscu C; Nguyen HL; Zarrabi K; Dufour A; Kadam P; Hu YJ; Pulkoski-Gross A; Bahou WF; Zucker S; Cao J
J Natl Cancer Inst; 2013 Sep; 105(18):1402-16. PubMed ID: 23990668
[TBL] [Abstract][Full Text] [Related]
4. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT.
Tang Z; Ding Y; Shen Q; Zhang C; Li J; Nazar M; Wang Y; Zhou X; Huang J
J Mol Med (Berl); 2019 Jan; 97(1):127-140. PubMed ID: 30478628
[TBL] [Abstract][Full Text] [Related]
5. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
Zhang D; Zhao L; Shen Q; Lv Q; Jin M; Ma H; Nie X; Zheng X; Huang S; Zhou P; Wu G; Zhang T
Int J Cancer; 2017 May; 140(10):2298-2309. PubMed ID: 28213952
[TBL] [Abstract][Full Text] [Related]
7. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
[TBL] [Abstract][Full Text] [Related]
8. YBX1 gene silencing inhibits migratory and invasive potential via CORO1C in breast cancer in vitro.
Lim JP; Shyamasundar S; Gunaratne J; Scully OJ; Matsumoto K; Bay BH
BMC Cancer; 2017 Mar; 17(1):201. PubMed ID: 28302118
[TBL] [Abstract][Full Text] [Related]
9. The miR-29c-KIAA1199 axis regulates gastric cancer migration by binding with WBP11 and PTP4A3.
Wang L; Yu T; Li W; Li M; Zuo Q; Zou Q; Xiao B
Oncogene; 2019 Apr; 38(17):3134-3150. PubMed ID: 30626935
[TBL] [Abstract][Full Text] [Related]
10. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo.
Yang Q; Ji G; Li J
Cancer Biol Ther; 2020; 21(3):278-291. PubMed ID: 31696760
[TBL] [Abstract][Full Text] [Related]
11. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
12. Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors.
Tiwari A; Schneider M; Fiorino A; Haider R; Okoniewski MJ; Roschitzki B; Uzozie A; Menigatti M; Jiricny J; Marra G
PLoS One; 2013; 8(7):e69473. PubMed ID: 23936024
[TBL] [Abstract][Full Text] [Related]
13. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
[TBL] [Abstract][Full Text] [Related]
14. KIAA1199 promotes metastasis of colorectal cancer cells via microtubule destabilization regulated by a PP2A/stathmin pathway.
Zhao L; Zhang D; Shen Q; Jin M; Lin Z; Ma H; Huang S; Zhou P; Wu G; Zhang T
Oncogene; 2019 Feb; 38(7):935-949. PubMed ID: 30202098
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
16. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
Westbrook JA; Wood SL; Cairns DA; McMahon K; Gahlaut R; Thygesen H; Shires M; Roberts S; Marshall H; Oliva MR; Dunning MJ; Hanby AM; Selby PJ; Speirs V; Mavria G; Coleman RE; Brown JE
J Pathol; 2019 Mar; 247(3):381-391. PubMed ID: 30426503
[TBL] [Abstract][Full Text] [Related]
17. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
[TBL] [Abstract][Full Text] [Related]
18. RING1 and YY1 binding protein suppresses breast cancer growth and metastasis.
Zhou H; Li J; Zhang Z; Ye R; Shao N; Cheang T; Wang S
Int J Oncol; 2016 Dec; 49(6):2442-2452. PubMed ID: 27748911
[TBL] [Abstract][Full Text] [Related]
19. Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells.
Birkenkamp-Demtroder K; Maghnouj A; Mansilla F; Thorsen K; Andersen CL; Øster B; Hahn S; Ørntoft TF
Br J Cancer; 2011 Aug; 105(4):552-61. PubMed ID: 21772334
[TBL] [Abstract][Full Text] [Related]
20. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
